Search

TORS for patients with sleep-disordered breathing

Transoral robotic surgery is now a well-accepted technique in malignant tumours of the tongue base. Here the team from St Mary’s and the Royal National Throat Nose & Ear Hospital in London describe its use in carefully selected patients with...

The effects of polypharmacy in the elderly

Another pill to cure the ill? Alec Lapira discusses the warning signs of polypharmacy in the elderly population. Polypharmacy in the elderly Polypharmacy – defined as the use of five or more medications – occurs in 20–37% of older people...

ENT Wallabies

Juggling the demands of elite sport, a boisterous social life on tour and medical academia would seem too much for mere mortals. All in a day’s work for your average Wallaby. Currently I am a Senior Visiting Medical officer at...

HPV and ENT; should we vaccinate boys?

David Black and Charlie Hall reiterate Vin Paleri’s pleas for a common sense evidence-based approach by those who allocate healthcare resources to the now urgent issue of HPV-related disease. They discuss the merits of different vaccines and the need for...

Sugammadex

Scott Russell is an anaesthetist with an almost unrivalled experience of complex head and neck surgery, and has seen all manner of new ideas come and go. However, in this article he describes a new pharmaceutical agent that is already...

In conversation with Professor Gerry O’Donoghue, Master of BACO 2020

We sent Priya Achar and Tawakir Kamani to interview Professor Gerry O’Donoghue, Master of BACO 2020, who has lots to tell us about the modern, collaborative, global, environmental and family friendly ethos of the event. First of all, why BACO...

OBITUARY: Alan Gibb (1919-2020)

Alan Gibb, who passed away on 5 September aged 101, was the Grand Old Man of British Otology. He slipped quietly away at home on Deeside from the long-term consequences of a stroke about two years ago, from which he...

Access to and uptake of cochlear implants in the UK

Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...

What’s new in genetic testing for hearing impairment?

Often the first question following the diagnosis of a hearing loss is ‘why?’ In this article Ali Danesh explores the advances made in uncovering ‘why’ from a genetics perspective. Ali describes the panel of genetic tests now commercially available to...